Novel Therapeutic Technologies
Wilmington · Founded 2003
About Novel Therapeutic Technologies
Novel Therapeutic Technology Inc. (NTT) is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT’s Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient's quality of life.
Company Facts
- Founded: 2003
- Legal name: Novel Therapeutic Technology Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $500K – $1M
- Total funding: $75.0M
- Last round: Series Unknown (Dec 2011)
- Website: ntt-inc.com
- Phone: +1 302-571-1128
Social Profiles
Canonical: https://fsome.com/organization/novel-therapeutic-technologies-8295007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.